History of Metabolic Treatments in Burn Care
- 0 Comments
- 7350 reads
Throughout the latter portion of the 20th century, major developments and advances within the specialty of burn care have been made. Several interventions and developments in reducing energy demands following burns have played a role in attenuating the metabolic response and reducing energy requirements. As a result, long-term function and prognosis have greatly improved. These interventions include early burn excision and wound closure with skin grafts or substitutes, early and aggressive enteral feeding, elevating environmental temperature to thermal neutrality, and pharmacological therapies to modulate the hypermetabolic response. Other developments include improved antimicrobial agents and treatment rationales, as well as efficacious topical antimicrobials and burn dressings that have led to prevention, earlier recognition, and treatment of sepsis.
Severe burn injuries induce an array of metabolic and physiologic processes to activate and respond in an attempt to restore homeostasis. The stress response following severe burns (approximately ≥ 40% total body surface area [TBSA]) is exaggerated and manifests detrimentally as hypermetabolism and associated profound catabolism. Features of the hypermetabolic response are known to include prolonged elevation in circulating catecholamines, cortisol, and glucagon.1 This results in associated elevation in gluconeogenesis, glycogenolysis, and muscle catabolism as well as other features including insulin resistance and impairment of lipolysis. Metabolic disturbances continue well past the acute phase following severe burns and may persist for more than a year after injury.
A large study from a burn unit in the United Kingdom covering the decade prior to 1954 showed 50% mortality in children with a burn of 50% TBSA.2 The authors later compared burn units from 1918–1948 and found that overall mortality was 50% in the 0–14 year age group of patients with 30% TBSA burns, and more than 90% mortality in patients with 40% surface area burns. Bull and Fisher2 of the UK Medical Research Council attributed the observed improvements at Jackson’s Birmingham unit in 1954 to factors including recognition of the value of transfusion for shock, control of infection, and early surgery. By the late 1990s, pediatric burn mortality in specialized burn units was less than 50% for 91%–95% TBSA burns.3 Factors that remain associated with poor outcomes include very young age, inhalation injury, delayed resuscitation, sepsis, and multi-organ failure.
The primary mediators of the catabolic response following burns are catecholamines,4 which rise up to 10-fold following burns with greater than 40% TBSA.5 Wilmore et al4,6 showed in 1974 and 1975 that following severe burns, metabolism and catecholamine levels could also be reduced by increasing ambient temperature to 33˚C, and also be modulated with alpha- and beta-adrenergic antagonists. They found the hypermetabolic response directly correlated with elevated catecholamine levels, which routinely increased 5-fold above normal following severe burns, and hence, promoted muscle catabolism and lipolysis. Wilmore and colleagues7 affirmed that burned extremities display increased glucose uptake and lactate production, and suggested that systemic responses act to increase peripheral blood flow in an attempt to supply the energy needs of the healing burn wound, thus, promoting hypermetabolism.
1. Bessey PQ, Watters JM, Aoki TT, Wilmore DW. Combined hormonal infusion simulates the metabolic response to injury. Ann Surg. 1984;200(3):264–281.
2. Bull JP, Fisher AJ. A study of mortality in a burns unit: a revised estimate. Ann Surg. 1954;139(3):269–274.
3. Wolf SE, Rose JK, Desai MH, Mileski JP, Barrow RE, Herndon DN. Mortality determinants in massive pediatric burns. An analysis of 103 children with > or = 80% TBSA burns (> or = 70% full-thickness). Ann Surg. 1997;225(5):554–569.
4. Wilmore DW, Long JM, Mason AD Jr., Skreen RW, Pruitt BA, Jr. Catecholamines: mediator of the hypermetabolic response to thermal injury. Ann Surg. 1974;180(4):653–669.
5. Wilmore DW, Aulick LH. Metabolic changes in burned patients. Surg Clin North Am. 1978;58(6):1173–1187.
6. Wilmore DW, Mason AD Jr., Johnson DW, Pruitt BA Jr. Effect of ambient temperature on heat production and heat loss in burn patients. J Appl Physiol. 1975;38(4):593–597.
7. Wilmore DW, Aulick LH, Mason AD, Pruitt BA Jr. Influence of the burn wound on local and systemic responses to injury. Ann Surg. 1977;186:444–458.
8. Hart DW, Wolf SE, Chinkes DL, et al. Determinants of skeletal muscle catabolism after severe burn. Ann Surg. 2000;232(4):455–465.
9. Hart DW, Wolf SE, Mlcak R, et al. Persistence of muscle catabolism after severe burn. Surgery. 2000;128(2):312–319.
10. Baron PW, Barrow RE, Pierre EJ, Herndon DN. Prolonged use of propranolol safely decreases cardiac work in burned children. J Burn Care Rehabil.1997;18(3):223–227.
11. Herndon DN, Barrow RE, Rutan TC, Minifee P, Jahoor F, Wolfe RR. Effect of propranolol administration on hemodynamic and metabolic responses of burned pediatric patients. Ann Surg. 1988;208(4):484–492.
12. Herndon DN, Hart DW, Wolf SE, Chinkes DL, Wolfe RR. Reversal of catabolism by beta-blockade after severe burns. N Engl J Med. 2001;345(17):1223–1229.
13. Minifee PK, Barrow RE, Abston S, Desai M, Herndon DN. Improved myocardial oxygen utilization following propranolol infusion in adolescents with postburn hypermetabolism. J Pediatr Surg. 1989;24(8):806–811.
14. Barrow RE, Wolfe RR, Dasu MR, Barrow LN, Herndon DN. The use of beta-adrenergic blockade in preventing trauma-induced hepatomegaly. Ann Surg. 2006;243;(1):115–120.
15. Barret JP, Jeschke MG, Herndon DN. Fatty infiltration of the liver in severely burned pediatric patients: autopsy findings and clinical implications. J Trauma. 2001;51(4):736–739.
16. Jeschke MG, Norbury WB, Finnerty CC, Branski LK, Herndon DN. Propranolol does not increase inflammation, sepsis, or infectious episodes in severely burned children. J Trauma. 2007;62(3):676–681.
17. Jeschke MG, Finnerty CC, Suman OE, Kulp G, Mlcak RP, Herndon DN. The effect of oxandrolone on the endocrinologic, inflammatory, and hypermetabolic responses during the acute phase postburn. Ann Surg. 2007;246(3):351–362.
18. Pearson E, Prudden JF, Soroff HS. The influence of growth hormone on the nitrogen balance of the severely burned. Surg Forum. 1956;6:76–77.
19. Wilmore DW, Moylan JA Jr, Bristow BF, Mason AD Jr, Pruitt BA Jr. Anabolic effects of human growth hormone and high caloric feedings following thermal injury. Surg Gynecol Obstet. 1974;138(6):875–884.
20. Knox J, Demling R, Wilmore D, Sarraf P, Santos A. Increased survival after major thermal injury: the effect of growth hormone therapy in adults. J Trauma. 1995;39(3):526–530.
21. Gore DC, Honeycutt D, Jahoor F, Wolfe RR, Herndon DN. Effect of exogenous growth hormone on whole-body and isolated-limb protein kinetics in burned patients. Arch Surg. 1991;126(1):38–43.
22. Gilpin DA, Barrow RE, Rutan RL, Broemeling L, Herndon DN Recombinant human growth hormone accelerates wound healing in children with large cutaneous burns. Ann Surg. 1994;220(1):19–24.
23. Herndon DN, Barrow RE, Kunkel KR, Broemeling L, Rutan RL. Effects of recombinant human growth hormone on donor-site healing in severely burned children. Ann Surg. 1990;212(4):424–431.
24. Przkora R, Herndon DN, Suman OE, et al. Beneficial effects of extended growth hormone treatment after hospital discharge in pediatric burn patients. Ann Surg 2006;243(6):796–803.
25. Barret JP, Dziewulski P, Jeschke MG, Wolf SE, Herndon DN. Effects of recombinant human growth hormone on the development of burn scarring. Plast Reconstr Surg. 1999;104(3):726–729.
26. Berger JR, Pall L, Hall CD, Simpson DM, Berry PS, Dudley R. Oxandrolone in AIDS-wasting myopathy. AIDS. 1996;10(14):1657–1662.
27. Mendenhall CL, Moritz TE, Roselle GA, et al. A study of oral nutritional support with oxandrolone in malnourished patients with alcoholic hepatitis: results of a Department of Veterans Affairs cooperative study. Hepatology. 1993;17(4):564–576.
28. Demling RH, DeSanti L. Oxandrolone, an anabolic steroid, significantly increases the rate of weight gain in the recovery phase after major burns. J Trauma. 1997;43(1):47–51.
29. Hart DW, Wolf SE, Ramzy PI, et al. Anabolic effects of oxandrolone after severe burn. Ann Surg. 2001;233(4):556–564.
30. van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in the critically ill patients. N Engl J Med. 2001;345(19):1359–1367.
31. Sakurai Y, Aarsland A, Herndon DN, et al. Stimulation of muscle protein synthesis by long-term insulin infusion in severely burned patients. Ann Surg. 1995;222(3):283–297.
32. Aarsland A, Chinkes DL, Sakurai Y, Nguyen TT, Herndon DN, Wolfe RR. Insulin therapy in burn patients does not contribute to hepatic triglyceride production. J Clin Invest. 1998;101(10):2233–2239.
33. Wolfe RR, Durkot MJ, Allsop JR, Burke JF. Glucose metabolism in severely burned patients. Metabolism. 1979;28(10):1031–1039.
34. Tompkins RG, Remensnyder JP, Burke JF, et al. Significant reductions in mortality for children with burn injuries through the use of prompt eschar excision. Ann Surg. 1988;208(5):577–585.
35. Hart DW, Wolf SE, Chinkes DL, et al. Effects of early excision and aggressive enteral feeding on hypermetabolism, catabolism, and sepsis after severe burn. J Trauma. 2003;54(4):755–764.
36. Janzekovic Z. A new concept in the early excision and immediate grafting of burns. J Trauma. 1970;10(12):1103–1108.
37. Engrav LH, Heimbach DM, Reus JL, Harnar TJ, Marvin JA. Early excision and grafting vs. nonoperative treatment of burns of indeterminant depth: a randomized prospective study. J Trauma. 1983;23(11):1001–1004.
38. Herndon DN, Barrow RE, Rutan RL Rutan TC, Desai MH, Abston S. A comparison of conservative versus early excision. Therapies in severely burned patients. Ann Surg. 1989;209(5): 547–553.
39. Barrow RE, Spies M, Barrow LN, Herndon DN. Influence of demographics and inhalation injury on burn mortality in children. Burns. 2004;30(1):72–77.
40. Herndon DN, Gore D, Cole M, et al. Determinants of mortality in pediatric patients with greater than 70% full-thickness total body surface area thermal injury treated by early total excision and grafting. J Trauma. 1987;27(2):208–212.
41. Muller MJ, Herndon DN. The challenge of burns. Lancet. 1994;343(8891):216–220.
42. Barret JP, Herndon DN. Modulation of inflammatory and catabolic responses in severely burned children by early burn wound excision in the first 24 hours. Arch Surg. 2003;138(2):127–132.
43. Moyer CA, Brentano L, Gravens DL, Margraf HW, Monafo WW Jr. Treatment of large human burns with 0.5 percent silver nitrate solution. Arch Surg. 1965;90:812–867.
44. Lindberg RB, Moncrief JA, Switzer WE, Order SE, Mills W Jr. The successful control of burn wound sepsis. J Trauma. 1965;5(5):601–616.
45. Fox CL Jr, Rappole BW, Stanford W. Control of pseudomonas infection in burns by silver sulfadiazine. Surg Gynecol Obstet. 1969;128(5):1021–1026.
46. Barr PO, Birke G, Liliedal' SO. [The treatment of thermal burns with dry, warm air]. Eksp Khir Anesteziol. 1968;13(2): 39–43.
47. Zawacki BE, Spitzer KW, Mason AD Jr, Johns LA. Does increased evaporative water loss cause hypermetabolism in burned patients? Ann Surg. 1970;171(2):236–240.
48. Newsome TW, Mason AD Jr., Pruitt BA Jr. Weight loss following thermal injury. Ann Surg. 1973;178(2):215–217.
49. Wilmore DW. Nutrition and metabolism following thermal injury. Clin Plast Surg. 1974;1(4):603–619.
50. Soeters PB, van de Poll MC, van Gemert WG, Dejong CH. Amino acid adequacy in pathophysiological states. J Nutr. 2004;134(6 Suppl):1575S–1582S.
51. Shaffer PA, Coleman W. Protein metabolism in typhoid fever. Arch Intern Med. 1909;4: 538–600.
52. Wilmore DW, Curreri PW, Spitzer KW, Spitzer ME, Pruitt BA Jr. Supranormal dietary intake in thermally injured hypermetabolic patients. Surg Gynecol Obstet. 1971;132(5):881–886.
53. Curreri PW, Richmond D, Marvin J, Baxter CR. Dietary requirements of patients with major burns. J Am Diet Assoc. 1974;65(4):415–417.
54. Peck M. Practice guidelines for burn care: nutritional support. J Burn Care Rehabil. 2001;22:59S–66S.
55. Waymack JP, Herndon DN. Nutritional support of the burned patient. World J Surg. 1992;16(1):80–86.
56. Wolfe RR, Goodenough RD, Burke JF. Wolfe MH. Response of protein and urea kinetics in burn patients to different levels of protein intake. Ann Surg. 1983;197(2):163–171.
57. Alexander JW, MacMillan BG, Stinnett JD, et al. Beneficial effects of aggressive protein feeding in severely burned children. Ann Surg. 1980;192(4):505–517.
58. Lee JO, Benjamin D, Herndon DN. Nutrition support strategies for severely burned patients. Nutr Clin Pract. 2005;20(3):325–330.
59. Herndon DN, Stein MD, Rutan TC, Abston S, Linares H. Failure of TPN supplementation to improve liver function, immunity, and mortality in thermally injured patients. J Trauma. 1987;27(2):195–204.
60. Herndon DN, Barrow RE, Stein M, et al. Increased mortality with intravenous supplemental feeding in severely burned patients. J Burn Care Rehabil. 1989;10(4):309–313.
61. Alverdy JC, Aoys E, Moss GS. Total parenteral nutrition promotes bacterial translocation from the gut. Surgery. 1988;104(2):185–190.
62. Suman OE, Thomas SJ, Wilkins JP, Mlcak RP, Herndon DN. Effect of exogenous growth hormone and exercise on lean mass and muscle function in children with burns. J Appl Physiol. 2003;94(6):2273–2281.
63. Suman OE, Spies RJ, Celis MM, Mlcak RP, Herndon DN. Effects of a 12-wk resistance exercise program on skeletal muscle strength in children with burn injuries. J Appl Physiol. 2001;91(3):1168–1175.